Investor Relations

ALXN (NASDAQ)

Last $ 138.82
Change 1.73%
02.10.16 4:00 PM ET

Events

Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2015 Results
Wed, 03 Feb, 2016 - 10:00 AM ET
Listen to Webcast »

PDF View Presentation   1.7 MB   Add to Briefcase
Alexion to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Thu, 11 Feb, 2016 - 1:50 PM ET
Listen to Webcast »

Note: Alexion Pharmaceuticals, Inc. provides this data for informational and research purposes only. The data is not intended for trading purposes. Neither Alexion nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.